Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Bridge Therapeutics Logo
Bridge Therapeutics Growth Score
55
CB Rank
113791
Heat Score
31
Bridge Therapeutics is a pharmaceutical company.
Founded
obfuscation
PrivateSeries A Birmingham, Alabama, United States1-10 www.bridgetherapeutics.com/
Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
Service Industry
Overview

Bridge Therapeutics
Total Funding
obfuscation
Growth Score
55
Heat Score
31

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score55
-4 pts
in past quarter
Heat Score 31
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Bridge Therapeutics

CB Rank
113791
Bridge Therapeutics is a pharmaceutical company.
Founded
obfuscation
PrivateSeries A Birmingham, Alabama, United States1-10 www.bridgetherapeutics.com/
Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
Service Industry

Funding Rounds

Series A
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Bridge Therapeutics
Operating Status Active
Company Type For Profit
Founders  Greg Sullivan
About the Company
Bridge Therapeutics they provide service in chronic pain and opioid addiction.
Phone Number +1 877 223-6949
Contact Email info@bridgetherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Buprenorphine-based Treatments
Pharmaceutical products containing buprenorphine used to treat opioid use disorder and chronic pain management.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A
obfuscation
Series A - Bridge Therapeutics Logo
Series A - Bridge Therapeutics
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 3

Employee Profiles

News

News and Press

News•Sep 25, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 10, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 7, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$84.5KThis year, Bridge Therapeutics is projected to spend $84.5K on IT, according to Aberdeen.

Active Website Tech Count

3Bridge Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.

Total IP

1Bridge Therapeutics has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Bridge Therapeutics's headquarters? Bridge Therapeutics is located in Birmingham, Alabama, United States.When was the last funding round for Bridge Therapeutics? Bridge Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are Bridge Therapeutics's competitors? Alternatives and possible competitors to Bridge Therapeutics may include Reckitt, Hikma Pharmaceuticals, and  Braeburn.How much funding has Bridge Therapeutics raised to date? Bridge Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c26e0ea 1)
|